Robert I. Tepper, 10% Owner at Jounce Therapeutics, Inc. (JNCE), sold 15,000 shares at $7.01 ($105K) on 2020-11-19, disclosed to the SEC on 2020-11-23.
Open-market sale of $105k JNCE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RVMD | SELL | 2021-06-07 | $32.8M | — | Filing → |
| RLAY | SELL | 2021-01-14 | $312.2M | — | Filing → |
| CNST | BUY | 2018-07-24 | $4.0M | — | Filing → |